Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #90,431 to #90,480.
- (hist) KIF3C [3,825 bytes]
- (hist) POU4F3 [3,825 bytes]
- (hist) Acinic cell carcinoma medical therapy [3,825 bytes]
- (hist) Corneal abrasion [3,826 bytes]
- (hist) Eye proptosis [3,826 bytes]
- (hist) Great Plague of Marseille [3,826 bytes]
- (hist) Existential crisis [3,826 bytes]
- (hist) Graph cuts in computer vision [3,826 bytes]
- (hist) National Board of Chiropractic Examiners [3,826 bytes]
- (hist) Xenobiotic-transporting ATPase [3,826 bytes]
- (hist) James Israel [3,826 bytes]
- (hist) Supraventricular tachycardia physical examination [3,826 bytes]
- (hist) Sandbox:DD HA [3,826 bytes]
- (hist) Sirenomelia [3,827 bytes]
- (hist) Toxin [3,827 bytes]
- (hist) Chlorendic acid [3,827 bytes]
- (hist) Mesoridazine [3,827 bytes]
- (hist) Bavituximab [3,827 bytes]
- (hist) Strained silicon [3,827 bytes]
- (hist) Trichotillomania (patient information) [3,827 bytes]
- (hist) Chronic kidney diseas [3,827 bytes]
- (hist) Pyelonephritis laboratory findings [3,827 bytes]
- (hist) Intussusception physical examination [3,827 bytes]
- (hist) MYO1E [3,827 bytes]
- (hist) TSPYL1 [3,827 bytes]
- (hist) Aspiration pneumonia CT scan [3,827 bytes]
- (hist) Premature ovarian failure [3,828 bytes]
- (hist) Viremia [3,828 bytes]
- (hist) Palaeeudyptes antarcticus [3,828 bytes]
- (hist) Statins found to be protective against recurrence of atrial fibrillation after cardioversion [3,828 bytes]
- (hist) The Living Guidelines: Oral Antiplatelet Therapy View the Current CLASS IIa Guidelines [3,828 bytes]
- (hist) Amoxicillin precautions [3,828 bytes]
- (hist) Obsessive-compulsive disorder other imaging findings [3,828 bytes]
- (hist) Parotitis causes [3,828 bytes]
- (hist) Creutzfeldt-Jakob disease future or investigational therapies [3,828 bytes]
- (hist) Penicillin G potassium microbiology [3,828 bytes]
- (hist) M-Toluic acid [3,829 bytes]
- (hist) Mediastinum [3,829 bytes]
- (hist) The Living Guidelines: PCI after Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion Suggest Revisions to the CLASS I Guidelines [3,829 bytes]
- (hist) The Living Guidelines: Antiplatelet Agents/Anticoagulants: Warfarin View the Current CLASS I Guidelines [3,829 bytes]
- (hist) The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy Suggest Revisions to the CLASS IIb Guidelines [3,829 bytes]
- (hist) Esophageal cancer history and symptoms [3,829 bytes]
- (hist) Upper gastrointestinal bleeding primary prevention [3,829 bytes]
- (hist) The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study [3,829 bytes]
- (hist) Infectious colitis epidemiology and demographics [3,829 bytes]
- (hist) FAM155A [3,829 bytes]
- (hist) MAP3K9 [3,829 bytes]
- (hist) Sexcord/ stromal ovarian tumors risk factors [3,829 bytes]
- (hist) Paclitaxel (patient information) [3,830 bytes]
- (hist) Interatrial septum [3,830 bytes]